Literature DB >> 8422708

Effects of metastatic and non-metastatic mammary adenocarcinoma on tissue distribution of gallium-67 in the rat.

A Durakovic1.   

Abstract

The purpose of this work was to study the effect of metastatic and non-metastatic mammary adenocarcinoma on tissue distribution of gallium-67 (67 Ga) citrate in Fischer-344 female rats by the use of gamma counting techniques. The homogenate (0.1 mm) of a sample of metastatic and non-metastatic tumor was implanted by subcutaneous injection in the right footpad of each animal's hind extremity. The animals bearing metastatic tumor were studied 2-24 days and the non-metastatic group 2-30 days after the implantation of tumor homogenate. The control group consisted of four animals and tumor-bearing groups of seven to eight animals at each time point. All animals were injected with 1.11 MBq of 67Ga citrate by intravenous administration and sacrificed in halothane anesthesia 48 h later. The relative tissue uptake data are presented as arithmetical mean value with a standard error and graphically demonstrated as normalized data with respect to control. The results demonstrate that 67Ga citrate uptake was largely unaffected in most organs by the presence of either metastatic or non-metastatic tumor. Gallium-67 uptake, however, was significantly and consistently increased in the popliteal lymph nodes of the ipsilateral extremity of tumor implant in the metastatic group. No difference was observed in the non-metastatic tumor group. The findings of this experimental work indicate that the host reaction to the tumor does not modify the gallium uptake characteristics in the normal tissues of tumor-bearing animals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8422708     DOI: 10.1007/bf00880067

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  21 in total

1.  Gallium-67 citrate uptake by cultured tumor cells, stimulated by serum transferrin.

Authors:  R G Sephton; A W Harris
Journal:  J Natl Cancer Inst       Date:  1975-05       Impact factor: 13.506

2.  Usefulness of gallium scintigraphy in primary and metastatic breast carcinoma.

Authors:  S D Richman; J N Ingle; S M Leveson; D C Neifeld; D C Tormey; A E Jones; G S Johnston
Journal:  J Nucl Med       Date:  1975-11       Impact factor: 10.057

3.  Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum.

Authors:  L Kostakoglu; S D Yeh; C Portlock; R Heelan; T J Yao; D Niedzwiecki; S M Larson
Journal:  J Nucl Med       Date:  1992-03       Impact factor: 10.057

4.  A study of the macromolecular binding of 67Ga in normal and malignant animal tissues.

Authors:  R L Hayes; J E Carlton
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

5.  Evidence for granulocytic incorporation of 67gallium in chronic granulocytic leukemia.

Authors:  J C Arseneau; R Aamodt; G S Johnston; G P Canellos
Journal:  J Lab Clin Med       Date:  1974-03

6.  Clinical evaluation of 67 Ga-citrate scanning.

Authors:  T Higasi; Y Nakayama; A Murata; M Sugiyama; K Nakamura
Journal:  J Nucl Med       Date:  1972-03       Impact factor: 10.057

7.  The incorporation of 67 Ga in normal and malignant cells and its dependence on growth rate.

Authors:  P Bichel; H H Hansen
Journal:  Br J Radiol       Date:  1972-03       Impact factor: 3.039

8.  Gallium-67 localization in lysosomal-like granules of leukemic and nonleukemic murine tissues.

Authors:  D C Swartzendruber; B Nelson; R L Hayes
Journal:  J Natl Cancer Inst       Date:  1971-05       Impact factor: 13.506

Review 9.  Gallium-67 citrate scanning in malignant lymphoma.

Authors:  R E Henkin
Journal:  CRC Crit Rev Clin Radiol Nucl Med       Date:  1975-11

10.  Effects of a metastatic (13762) and nonmetastatic (R3230AC) mammary adenocarcinoma on radiocolloid localization in regional lymph nodes in Fischer 344 rats.

Authors:  G N Ege; J B Nold; R R Eng; A Durakovic; J J Conklin
Journal:  J Reticuloendothel Soc       Date:  1983-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.